Literature DB >> 24635954

[Cutaneous mucormycosis caused by Rhizopus microsporus].

G Desoubeaux1, M Leperlier2, H Chaussade3, C Schneider3, M Roriz4, C Houssin2, C Rogez5, A De Muret5, D García-Hermoso6, É Bailly2, É Le Fourn4, L Machet7, J Chandenier8, L Bernard9.   

Abstract

BACKGROUND: Mucormycosis are rare fungal infections occurring chiefly in the lung or the rhinocerebral compartment, particularly in patients with immunodeficiency or mellitus diabetes. We report the case of an elderly patient with cutaneous mucormycosis caused by Rhizopus microsporus. PATIENTS AND METHODS: An 89-year-old man presented a skin lesion of the forearm rapidly becoming inflammatory and necrotic. The patient had been treated for 2months with oral corticosteroids for idiopathic thrombocytopenia. Histological and mycological examination of the skin biopsy revealed the presence of a filamentous fungus, R. microsporus. The outcome was unfavorable, despite prescription of high-dose liposomal amphotericin B. DISCUSSION: Mucormycosis are infrequent opportunistic infections caused by angio-invasive fungi belonging to the Mucorales order. Cutaneous presentations are rare, and in rare cases the species R. microsporus is isolated in clinical samples. Diagnosis is based on histological examination highlighting the characteristic mycelium within infected tissue, together with ex vivo mycological identification using morphological and molecular methods. Treatment consists of liposomal amphotericin B combined with debridement surgery.
CONCLUSION: R. microsporus is a marginal fungal species rarely isolated in clinical practice, and even less in dermatology departments. This clinical case report highlights the severity of infection with this fungus, particularly in the absence of early surgery.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Amphotéricine B liposomale; Chirurgie; Corticosteroids; Corticoïdes; Cutaneous mucormycosis; Debridement surgery; Liposomal amphotericin B; Mucormycose cutanée; Rhizopus microsporus

Mesh:

Substances:

Year:  2013        PMID: 24635954     DOI: 10.1016/j.annder.2013.10.044

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  2 in total

1.  Cutaneous mucormycosis caused by Rhizopus microsporus in an immunocompetent patient: A case report and review of literature.

Authors:  Yilun Wang; Min Zhu; Yunqi Bao; Li Li; Liping Zhu; Feng Li; Jinhua Xu; Jun Liang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

2.  Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment.

Authors:  Norbert Harrasser; Ingo J Banke; Matthias Hauschild; Ulrich Lenze; Peter M Prodinger; Andreas Toepfer; Christian Peschel; Rüdiger von Eisenhart-Rothe; Ingo Ringshausen; Mareike Verbeek
Journal:  BMC Infect Dis       Date:  2014-09-06       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.